Bayer considers pulling Roundup from U.S. market after judge rejects $2 billion settlement deal

After a U.S. judge rejected a $2 billion plan to settle all future claims alleging that glyphosate (Roundup) herbicide causes cancer, Bayer, which took the baton from Monsanto, is reportedly rethinking the chemical’s presence in the American consumer market. At this point in time, there are some 30,000 ongoing lawsuits involving Roundup, which has injured and … Continue reading Bayer considers pulling Roundup from U.S. market after judge rejects $2 billion settlement deal